Перейти до головного Перейти в головне навігаційне меню Перейти на нижній колонтитул сайту
Опубліковано: 2017-09-07

Особливості когнітивної дисфункції у пацієнтів з депресивним розладом на фоні цереброваскулярної патології

Український науково-дослідний інститут соціальної і судової психіатрії та наркології
depression organic depressive disorder cognitive dysfunction attention executive function депресія органічний депресивний розлад когнітивні порушення увага виконавча функція


Актуальність. Останніми роками спостерігається зростання кількості населення похилого віку, а разом з тим і нагромадження психічних і соматичних хвороб, притаманих цій віковій категорії. Депресія, деменція та серцево-судинні захворювання продовжують займати провідні позиції в загальному рейтингу захворювань. Синдром виконавчої дисфункції у пацієнтів з органічним депресивним розладом на тлі цереброваскулярної патології є однією із патогномонічних ознак порушення вищих мозкових функцій при субкортикальній ішемічній депресії, що важливо для прогнозу захворювання, надання своєчасної медичної допомоги, розробки профілактичних заходів та покращення якості життя пацієнтів.

Матеріали і методи. За допомогою тестів ТМТ та тесту Струпа було обстежено 138 пацієнта з депресивним розладом з метою виявлення когнітивної дисфункції.

Результати. Більш виражена когнітивна дисфункція у вигляді порушення виконавчої функції, пізнавального контролю, обсягу та розподілення уваги спостерігалась у пацієнтів з органічним депресивним розладом і ознаками субкортикальної ішемії ГМ. Відмінності у структурі порушень когніцій обумовлені зонами морфологічного ураження ГМ та розривом кортіко-стріарних шляхів.

Висновки. У пацієнтів з субкортикальною ішемічною депресією спостерігається синдром виконавчої дисфункції, якій є провідним при субкортикальній ішемічній деменції. Можливість розробки та впровадження комплексної програми для відновлення когнітивної дисфункції дозволить покращити якість життя пацієнтів.


People who suffer from mental disorders demonstrate a significant decrease in viability and disproportionate increase in mortality. Depression is one of the most common mental disorders among Ukrainian and many other populations in recent years. It’s closely associated with an increased risk of suicide, reduced functioning, and quality of life. From recent epidemiological studies in depressive disorders in the elderly can be seen a demographic shift toward later ages alongside with accumulation of mental, physical illnesses and their combination in this age group. Mental disorders can affect the physical condition and, conversely, they are influenced by other chronic somatic health problems such as cardiovascular diseases. The prevalence of mental disorders among older age groups is 3-7 times higher than in the general population cohort 1. About one-third of mental and behavioral disorders are referred to affective pathology, and the first place belongs to organic, including symptomatic, mental disorders (F00-F09) - 69%. Among them, leading positions are occupied by dementia and depressive disorders 2. Cardiovascular diseases are among the most common risk factors of depression in elderly. Forecasts of cardiovascular disease incidence suggest saving tendency to grow in the world and, particularly, in Ukraine 1. At the same time, the results of several studies had shown that the risk of vascular dementia is significantly increased in presence of depressive disorders in a premorbid period 3. Also, it was concluded that late depression can be a precursor and a risk factor for dementia. 4. In addition, the risk of vascular dementia in elderly patients with depression may be much higher than for Alzheimer's disease 5. Among the primary mechanisms of later life depression are immune and vascular components 6. Within many studies were found that increased indicators of inflammation in the peripheral blood contribute to the development of depression in the elderly. But, in turn, prolonged emotional distress is the basis for occurrence of inflammation and subsequent development of depression 7.

Cerebrovascular diseases are mostly the result of common diseases such as hypertension and atherosclerosis. Depending on the etiological factors can be distinguished micro- or macroangiopathy. The hypertension is characterized by microangiopathy of the brain and the initial vascular lesions of the basal ganglia and subcortical white matter. For atherosclerotic lesions is common macroangiopathy, which often develops as a result of acute cerebrovascular accident (CVA) 8.

The concept of vascular (microangiopathic) depression has been first proposed in 1997 by G.Alexopoulos, who noted that it occurs in people over 60 with chronic cerebral discirculation and alongside with such pathopsychological phenomena as psychomotor retardation, presence of cognitive dysfunction and reduced response to antidepressant treatment 9. MRI brain images of vascular depression demonstrate the increasing signal intensity in the deeper parts of white matter in frontal region and putamen. The result of microangiopathy is a development of ischemic regions in the gray and white matter of the brain, which leads to separation of neural networks.

Such changes are structural and potentially irreversible rather than functional, which explains the relative resistance to antidepressant therapy and sustained impairments of executive function 10. Executive dysfunction is an impairment of higher brain functions and includes impairment in planning, organization, implementation of multistage operations, regulation and control individual actions and behavior in general. Sometimes these cognitive disorders referred to as regulatory. The morphological structure of executive function is fronto-strial system, which ensures the purposeful selection of the most adequate action program at the moment, monitors its implementation and effectiveness, inhibits inadequate actions, corrects, and if necessary, replaces one program to another 11.

It is known that the incidence of depressive disorders is influenced by various factors such as gender, age, education, availability of unhealthy habits, socio-economic conditions, and others. Considering the difficult socio-economic circumstances in Ukraine in recent years, increasing in the number of elderly and female population, we can assume that the incidence of depression on the background of cerebrovascular disease will tend to increase. So, a high risk of dementia processes in organic depressive disorders causes a pathognomonic relevance of examining the mechanisms of depression and dementia.

Thus, it may be important for the prognosis of the disease and the provision of timely medical care to identify the features and differences of organic affective disorder in elderly patients with cerebrovascular diseases, depending on the etiopathogenetic mechanisms, as well as allocation of pathophysiological phenomena inherent in depression in subcortical ischemic brain damage.

Materials and methods

During the 2013-2016 patients were examined with obtaining the informed consent at the neurological department of CMU "City Hospital № 3" in Kramatorsk (Donetsk region) and the psychoneurological department of Kiev Railway Clinical Hospital № 1. In this study were included 138 patients aged 50 to 78 years (average age 63.6 years) who were divided into basic (BG) and the comparison group (CG), representative by age. According to a survey, BG patients were split into two groups: BG1 (F06.3 + presence of subcortical hyperintense lesions in the brain, according to MRI, n=38) and BG2 (F06.3 + CVA restorative period, n=32). A total of 68 participants with clinical depression and normal brain MRI image were included in the comparison group (CG). We used МОСА test for dementia excluding and TMT test and Stroop test for cognitive dysfunction subsequent identification.

The TMT test allows to make a differential diagnosis between the lack of attention concentration associated with a decrease in the activation of the cortex from the stem-subcortical structures side (the test runtime increase in part A and part B in proportion to the normal ratio) and bradyphrenia related to impairment of regulatory functions (increase in time of part B more than part A time) 12,13.

Additionally, speed of the visual search, mental mobility, strategy of passing, visual planning skills, and distributed attention were measured. It should be emphasized, that part A allowed to estimate dynamic parameters of attention and level of its arbitrary regulation, spatial orientation, and proper visual-motor coordination; part B - distributed attention, working memory and executive function. The estimated parameter was the time in seconds spent on the task. The more time was spent on the test, the greater was the deterioration in cognitive functioning.

Stroop Color Word Interference Test consists of tasks of varying difficulty and is used to assess the distribution of attention and executive functions. In particular, for this study, the main measures were time spent doing the test and the number of errors that were observed during the execution of this test. The main measured neuropsychological parameter was cognitive control, that is, the regulatory function. This test can be considered as the most sensitive to the pathology of the cortex, which is closely linked with the function of cognitive control. At the same time, this test is also sensitive to impairment of intellectual flexibility, which is to a large extent a function of dorsolateral frontal cortex 12,13.


In Table 1 are presented the indicators of attention and executive function in the studied groups. Indicators of attention measured by TMT-A had a statistically significant intergroup difference among patients with organic depressive disorder with signs of subcortical brain ischemia (BG1 group) compared with patients with post-stroke depression (BG2 group) (p<0.05). Also, the group of patients with signs of subcortical brain ischemia (BG1) demonstrated a statistically significant tendency to increase the time of TMT-B (assessment of allocation of attention, working memory and executive function) compared with the group of patients with depressive disorders without organic CNS lesion (CG group; p<0.01), and a group of patients with post-stroke depression (group BG2; p<0.05). The findings revealed more pronounced cognitive impairment in the volume and distribution of attention, working memory and executive function in patients suffering from organic depressive disorder and have signs of subcortical brain ischemia. Patients with poststroke depression (group BG2) had fastest time completion for the TMT-A task (attention span), but demonstrated a fairly significant slowdown in TMT-B task compared with a group of patients with depressive disorders without organic CNS lesion (group CG; p<0.05). However, compared with referent normal values all three groups revealed a decrease in task completion time of TMT test, which probably reflects a lack of functional regulation of cognitive processes in patients with depressive disorders, regardless of the disease origin (Table 1).

Indicator Study group / time (sec.) The significance of differences between groups
BG1, M ± σ BG2, M ± σ CG, M ± σ BG1 vs BG2 BG1 vs CG BG2 vs CG
TMT-A 54,6± 3,6 47,8±3,1 50,7± 3,7 p<0,05 p>0,05 p>0,05
TMT-B 120,3±3,8 113,0±3,4 105,6± 3,9 p<0,05 p<0,01 p<0,05
Table 1.Indicators of attention and executive function in patients with depressive disorders*M - arithmetic mean, σ - standard deviation

Figure 1.Indicators of attention and executive function in patients with depressive disorders

Patients with organic depressive disorder, regardless of lesion characteristics, had more pronounced impairment of executive function. According to the results of TMT-B testing, group BG1 had 120,3 ± 3,8 sec., BG2 group had 113.0 ± 3.4 sec., compared with 105.6 ± 3.9 sec. for group CG. The differences between experimental groups and control group was significant (p<0.01 and p<0.05, respectively). Attention impairment was more pronounced in the OG1 group (54.4 ± 3.6 seconds) compared with the OG2 group (47.8 ± 3.1 seconds), the difference was significant (p <0.05).

The number of errors during the test in both of its parts reliably prevailed in OG1 group, indicating a significant disturbance of attention function in patients with signs of chronic cerebrovascular disorder.

The assessment of executive function in groups with the presence of organic CNS lesions (BG1 and BG2) revealed even more deficits relative to the conditional norms. TMT-B time in these groups was also significantly higher in comparison with the CG group (respectively, BG1 vs. CG, p<0.01; BG2 vs. CG, p<0.05). Consequently, the presence of depression in cognitive impairment patients, regardless of the origin of the disease, caused slower task completion (TMT-B). At the same time, the amount of attention, its distribution and executive function, were most impaired in patients with an organic depressive disorder and coexisted signs of subcortical brain ischemia, i.e., with chronic cerebrovascular abnormalities.

Indicators of reading speed and selectivity of attention from the Stroop test are presented in Table 2.

Indicator Survey groups The significance of differences between groups
BG1, M ± σ BG2, M ± σ CG, M ± σ BG1 vs BG2 BG1 vs CG BG2 vs CG
Stroop Test, congruent, part 1 (time, sec.) 79.3±4.8 73.6±4.2 68.3± 3.4 p>0.05 p<0.01 p>0.05
Stroop Test, incongruent, part 2 (time, sec.) 123.6 ±5.5 111.4±4.6 98.2± 3.6 p<0.01 p<0.001 p<0.05
Errors, part 1 2.7±0.6 2.1±0.5 1.5±0.3 p>0.05 p<0.01 p>0.05
Errors, part 2 5.9±1.6 3.2±0.9 2.6±0.6 p<0.01 p<0.001 p>0.05
Table 2.Indicators of reading speed and attention selectivity in patients with depressive disorders*M - arithmetic mean, σ - standard deviation

Figure 2.Indicators of reading speed and attention selectivity in patients with depressive disorders

Upon assessing of the Stroup test congruent part indicators, there were no significant intergroup differences between groups BG1 and BG2, as well as between BG2 and CG groups (p> 0.05).

At the same time, the reading speed rates determined by this test in the BG1 group were significantly lower than in the CG group (the difference was significant, p <0.001). Also in all groups speed reading rates were lower than the norm. So, can be said that patients with depressive symptoms, regardless of the genesis of depression, had a deficit in a mental activity speed.

Regarding the performance of patients in incongruent second Stroop test (that evaluates cognitive mobility), the difference between groups was also significant. Patients in BG1 group coped with the task more slowly compared with other 2 groups (BG1 vs. BG2: p<0.01; BG1 vs. CG: p<0.001).

Such results reflect reasoning slowing and a certain rigidity of mental processes that are inherent in depressive disorders, similar to those given with the same type of stimuli in the first part of the test. It is noteworthy that the results, obtained from the second part of the Stroop test, had a more pronounced tendency for deterioration in all groups compared to the referent norms. These results reflect an increase in the test load on the attention switching, i.e., on the mobility of mental processes. The number of errors during the Stroop test in both of its parts was significantly more prevalent among patients from the BG1 group compared with GG group, what can be explained by a significant disturbance of attention function (especially, attention selectivity) in patients with subcortical brain ischemia. Stimuli contrast in the second part of Stroop test led to a decrease in the results compared to referent norms in all studied groups.

Indicator of control rigidity/flexibility, assessed as the difference in the execution time of incongruent and congruent part of Stroop test, was estimated at 44.3 sec. in the BG1 group, 37.8 sec. in the BG2 group and 29.9 sec. in the CG group. Consequently, the most pronounced effect of interference and, correspondingly, more severe rigidity (narrowness, stiffness) of cognitive control was observed in patients with organic depressive disorder with chronic cerebrovascular disorders. The number of errors was the highest also in BG1 group (p<0.01 compared to other groups).

Patients from BG1 group had a deficit of mental activity (123.6 ± 5.5 sec.) relative to CG group (98.2 ± 3.6 sec.) and BG2 group (111.4 ± 4.6 sec.) the difference was significant (p<0.001 and p<0.01 respectively). But the difference between BG2 and CG group was not significant (p>0.05). The obtained results demonstrate the presence of disturbances in attention selectivity, cognitive mobility, and speed of mental activity in depressive disorders, regardless of their genesis.


Thus, based on the conducted pathopsychological examination of patients with organic depressive disorder with cerebrovascular pathology and depressive disorder without signs of brain damage using TMT and Stroop tests for the detection of cognitive dysfunction, the following conclusions can be drawn:

  1. More severe cognitive impairment of volume and distribution of attention, working memory, cognitive control and executive function are defined in patients suffering from organic depressive disorder and having signs of subcortical brain ischemia.
  2. In comparison with the referent norms, patients from all three groups showed a significant slowing in performance on tasks for cognitive mobility and selective attention, what reflects a certain functional deficiency of cognitive processes regulation in patients with depressive disorders, regardless of their genesis.


  1. Pinchuk I. Herontopsykhiatrychna dopomoha: suchasni pidkhody. Ternopil: TzOV Terno-hraf; 2011.
  2. Pinchuk I, Chaikovska V, Stadniuk L, Levada O, Pustovoit M, Shyriaieva M. Aktualni pytannia herontopsykhiatrii. Ternopil: TzOV Terno-hraf; 2010.
  3. Bowirrat A, Oscar-Berman M, Logroscino G. Association of depression with Alzheimer’s disease and vascular dementia in an elderly Arab population of Wadi-Ara, Israel. Int J Geriatr Psychiatry. 2006;21(3):246-51.
  4. Silva J, Gonçalves-Pereira M, Xavier M, Mukaetova-Ladinska E. Affective disorders and risk of developing dementia: systematic review. The British Journal of Psychiatry. 2013;202(3):177-86.
  5. Diniz B, Butters M, Albert S, Dew M, Reynolds C. Late-life depression and Alzheimer’s disease: systematic review and meta analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329-35.
  6. Su L, Faluyi Y, Hong Y, Fryer T, Mak E, Gabel S, Hayes L, Soteriades S, Williams G, Arnold R, Passamonti L, Rodríguez P, Surendranathan A, Bevan-Jones R, Coles J, Aigbirhio F, Rowe J, O’Brien J. Neuroinflammatory and morphological changes in late-life depression: the NIMROD study. Br J Psychiatry. 2016;209(6):525-6.
  7. Evstyfeeva S, Shalnova S, Deev A. Assotsyatsyia depressyy s s-reaktyvnym belkom (dannye epydemyolohycheskoho yssledovanyia ESSE-RF). Ratsyonalnaia Farmakoterapyia v Kardyolohyy. 2016;12(2):129-37.
  8. Jellinger K. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci. 2013;10(5).
  9. Alexopoulos G, Meyers B, Young R, Campbell S, Silbersweig D, Charlson M. Validity of vascular depression as a specific diagnostic: a review. Arch Gen Psychiatry. 2007;33(1):39-48.
  10. Levin O. Diagnostika i lechenin dementsii v klinicheskoy praktike. Moskva: MEDpress-inform; 2014.
  11. Levada O. Osobennosti dismnesticheskikh narusheniy na etapakh razvitiya subkortikalnoy sosudistoy dementsii po dannym time-testa. Meditsinskaya psikhologiya. 2013;2:28-35.
  12. Zakharov V. Voznesenskaya TG. Nervno-psikhicheskiye narusheniya: diagnosticheskiye testy. Moskva: MEDpress-inform; 2013.